Phospho-specific plasma p-tau181 assay detects clinical as well as asymptomatic Alzheimer's disease
Objective: Plasma phosphorylated-tau-181 (p-tau181) reliably detects clinical Alzheimer's disease (AD) as well as asymptomatic amyloid-β (Aβ) pathology, but is consistently quantified with assays using antibody AT270, which cross-reacts with p-tau175. This study investigates two novel phospho-s...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
John Wiley and Sons Inc
2022
|
| Online Access: | View Fulltext in Publisher |